Trials
1 active
1 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Functional Dyspepsia
- Main trialPhase 4
- “This study will evaluate the efficacy and safety of DA-9701 in patients with functional dyspepsia”In the company’s words, NCT07686679 on ClinicalTrials.gov
Other drugs for Functional Dyspepsia
- TRX103Tr1X, Inc. · Phase 1/2
Coming up1
- Oct 2027Phase 4 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 4Recruiting | Oct 2027 | A Study to Evaluate the Efficacy and Safety of DA-9701 in Patients With Functional Dyspepsia |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026